BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
XETRA:BNN
Price:
2.82 EUR
0.71%
Market Closed
Updated:
May 3, 2024
BRAIN Biotech AG
Depreciation & Amortization
|
BRAIN Biotech AG
Depreciation & Amortization Peer Comparison
Comparables:
WCH
EVK
1COV
ACT
SY1
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
BRAIN Biotech AG
XETRA:BNN
|
Depreciation & Amortization
-€4.7m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Wacker Chemie AG
XETRA:WCH
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Evonik Industries AG
XETRA:EVK
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Covestro AG
XETRA:1COV
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
AlzChem Group AG
XETRA:ACT
|
Depreciation & Amortization
-€25.9m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
|
Symrise AG
XETRA:SY1
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is BRAIN Biotech AG's Depreciation & Amortization?
Depreciation & Amortization
-4.7m
EUR
-4.7m
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Depreciation & Amortization amounts to -4.7m EUR.
What is BRAIN Biotech AG's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-3%
-3%
Over the last year, the Depreciation & Amortization growth was -6%. The average annual Depreciation & Amortization growth rates for BRAIN Biotech AG have been -3% over the past three years , -3% over the past five years .
You don't have any saved screeners yet
